| Recruiting | Phase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected Tumors Solid Tumors, Sarcomas | Phase 1 | 2026-03-01 |
| Recruiting | A Study to Assess the Efficacy and Safety of ZL-1109 in Chinese Participants With Active Thyroid Eye Disease Thyroid Eye Disease (TED) | Phase 3 | 2025-12-05 |
| Recruiting | A Phase 1/1b Study to Evaluate Safety, Tolerability and Pharmacokinetics of ZL-1503 in Healthy Volunteers and Atopic Dermatitis (AD) | Phase 1 | 2025-12-01 |
| Recruiting | A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cance Small-cell Lung Cancer | Phase 3 | 2025-11-30 |
| Recruiting | A Study of ZL-1310 in Participants With Selected Solid Tumors Solid Tumors | Phase 1 / Phase 2 | 2025-05-12 |
| Recruiting | A Study of ZL-1310 in Subjects With Small Cell Lung Cancer SCLC | Phase 1 | 2024-01-23 |
| Completed | To Evaluate Pharmacokinetics of Tisotumab Vedotin in Chinese Subjects With Metastatic or Recurrent Solid Malig Solid Malignancies | Phase 1 | 2023-06-16 |
| Unknown | The Clinical Trial to Evaluate the Pharmacokinetics and Safety of MRTX849 in Patients With Advanced Solid Tumo Advanced or Metastatic Solid Tumor | Phase 1 | 2022-05-30 |
| Completed | A Study to Assess DCC-2618 and Sunitinib in Patients With Advanced GIST After Treatment With Imatinib Gastrointestinal Stromal Tumor(GIST) | Phase 2 | 2020-11-25 |
| Terminated | A Study to Evaluate the Safety and Efficacy of MGD013 in Patients With Melanoma Unresectable, Recurrent or Metastatic Melanoma, Untreated Mucosal or Acral Lentiginous Melanoma | Phase 1 | 2020-10-29 |
| Completed | A Study to Evaluate the Pharmacokinetics of Margetuximab in Chinese Patients With HER2+ MBC HER2 Positive Metastatic Breast Cancer | Phase 1 | 2020-08-25 |
| Completed | A Study of Niraparib in Patients With Relapsed Ovarian Cancer Ovarian Cancer | Phase 2 | 2020-08-04 |
| Completed | A Trial of ZL-1201 in Subjects With Advanced Cancer Advanced Cancer | Phase 1 | 2020-05-11 |
| Completed | A Study of DCC-2618 (Ripretinib) In Patients With With Advanced Gastrointestinal Stromal Tumors (GIST) Gastrointestinal Stromal Tumors | Phase 2 | 2020-04-23 |
| Terminated | MGD013 Monotherapy and Combination With Brivanib Dose Escalation and Expansion Study in Advanced Liver Cancer Advanced Hepatocellular Carcinoma (HCC) | Phase 1 / Phase 2 | 2020-04-20 |
| Terminated | A Study of Niraparib Combined With MGD013 in Patients With Advanced or Metastatic Solid Tumor Who Failed Prior Gastric Cancer, Triple Negative Breast Cancer, Biliary Tract Carcinoma | Phase 1 | 2020-02-03 |
| Unknown | A Study to Evaluate the Efficacy and Safety of Margetuximab Plus Chemotherapy in the Treatment of Chinese Pati Breast Cancer Metastatic | Phase 2 | 2020-01-13 |
| Terminated | A Study of Niraparib as Maintenance Therapy Following First-Line Platinum-Based Chemotherapy in Patients With Extensive-stage Small Cell Lung Cancer | Phase 3 | 2018-08-20 |
| Unknown | A Study of ZL-2306 (Niraparib) as Maintenance Treatment Following First-line Chemotherapy in Patients With Adv Ovarian Cancer | Phase 3 | 2018-06-30 |
| Completed | The Clinical Trial to Evaluate the Pharmacokinetics, Safety and Tolerability of ZL-2306 (Niraparib) in Patient Ovarian Cancer | Phase 1 | 2017-12-19 |
| Unknown | Clinical Trial Evaluating the Efficacy and Safety of ZL-2306 (Niraparib) in Ovarian Cancer Patient Platinum-sensitive Relapsed Ovarian Cancer | Phase 3 | 2017-06-08 |
| Completed | A Phase 2 Study of Brivanib in Chinese Patients With Previously Treated Advanced HCC Hepatocellular Carcinoma (HCC) | Phase 2 | 2017-05-17 |